Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Apr 23, 2025 (1 years ago)

Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP deviations and lack of assurance of sterility.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Carboxymethlycellulose Sodium 0.5% Eye Lubricant, Lubricating Eye Drops, Moisturizing, Sterile, 0.5 FL OZ (15mL) per dropper bottle, Distributed by: AvKARE, Pulaski, TN 38478, NDC: 50268-068-15.

Affected NDC 50268-0068-15

Compare with the code on your package — it is the most precise check available.

Category: Eye Drops & Ophthalmic

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
carboxymethylcellulose sodium
NDC 50268-0068
, UNSPECIFIED FORM 5 mg/mL Solution/ Drops
Ophthalmic
AvPAK OTC
Recalling firm
BRS Analytical Services, LLC
Origin
MO, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0406-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by BRS Analytical Services, LLC

All 2025 recalls

Other sterility / contamination recalls from 2025

All sterility / contamination recalls
Class II · Moderate risk

Vista Gonio Eye Lubricant

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Ongoing Sterility / contamination Wizcure Pharmaa Private Limited NDC 77790-022-15 D-0349-2026